Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.89 |
| ▸ | LMNA | P02545 | 2/20 | 0.76 |
| ▸ | AKR1B10 | O60218 | 4/20 | 0.69 |
| ▸ | AKR1B1 | P15121 | 4/20 | 0.69 |
| ▸ | CA12 | O43570 | 2/20 | 0.69 |
| ▸ | CA4 | P22748 | 2/20 | 0.69 |
| ▸ | CA6 | P23280 | 2/20 | 0.69 |
| ▸ | CA5A | P35218 | 2/20 | 0.69 |
| ▸ | CA7 | P43166 | 2/20 | 0.69 |
| ▸ | CA9 | Q16790 | 2/20 | 0.69 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.69 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.69 |
| ▸ | TTR | P02766 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.59 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL337503 | 1.00 | HCAR2 (0.89) | HCAR2LMNAAKR1B10AKR1B1CA12 | |
| SCHEMBL337504 | 1.00 | HCAR2 (0.89) | HCAR2LMNAAKR1B10AKR1B1CA12 | |
| SCHEMBL27659194 | 0.98 | HCAR2 (0.85) | HCAR2LMNAAKR1B10AKR1B1CA12 | |
| Benzyl Fumarate SCHEMBL166653 | 0.94 | HCAR2 (1.00) | HCAR2LMNAAKR1B10AKR1B1CA12 | |
| Benzyl Fumarate SCHEMBL527836 | 0.94 | HCAR2 (1.00) | HCAR2LMNAAKR1B10AKR1B1CA12 | |
| Benzyl Fumarate SCHEMBL165231 | 0.94 | HCAR2 (1.00) | HCAR2LMNAAKR1B10AKR1B1CA12 | |
| Benzyl Fumarate SCHEMBL9460386 | 0.94 | HCAR2 (1.00) | HCAR2LMNAAKR1B10AKR1B1CA12 | |
| Benzyl Fumarate SCHEMBL9436105 | 0.92 | HCAR2 (0.96) | HCAR2LMNAAKR1B10AKR1B1CA12 | |
| SCHEMBL30556980 | 0.92 | HCAR2 (0.77) | HCAR2LMNAAKR1B10AKR1B1CA12 | |
| Benzyl Fumarate SCHEMBL10876347 | 0.92 | HCAR2 (0.96) | HCAR2LMNAAKR1B10AKR1B1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 688 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114068065-B | Conductive material for temperature sensor and use thereof | 杭州安誉科技有限公司 | 2022-07-08 | — | — | CN | claimed |
| CN-113999113-B | Exercise protection type lens resin monomer, preparation method and production system thereof | 湖北巴乐福化工科技有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-113999113-A | Motion protection type lens resin monomer, preparation method and production system thereof | 湖北巴乐福化工科技有限公司 | 2022-02-01 | — | — | CN | claimed |
| CN-110637060-A | Epoxy acrylate resin composition for medium refractive optical lens and preparation method thereof | 可奥熙搜路司有限公司 | 2019-12-31 | — | — | CN | claimed |
| CN-110637040-A | Resin composition for epoxy acrylic medium refractive optical lens and preparation method thereof | 可奥熙搜路司有限公司 | 2019-12-31 | — | — | CN | claimed |
| CN-110337456-A | Resin composition for epoxy acrylic refractive optical lens and preparation method thereof | 可奥熙搜路司有限公司 | 2019-10-15 | — | — | CN | claimed |
| WO-2019143560-A9 | METHODS FOR PROMOTING MITOCHONDRIAL BIOGENESIS IN NEURAL CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-09-12 | — | — | WO | claimed |
| WO-2019143560-A1 | METHODS FOR PROMOTING MITOCHONDRIAL BIOGENESIS IN NEURAL CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-07-25 | — | — | WO | claimed |
| US-20190111016-A1 | METHODS OF TREATING MUSCLE AND LIVER DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-04-18 | — | — | US | claimed |
| EP-3156433-B1 | COATING COMPOSITIONS INCLUDING A POLYISOCYANATE CHAIN EXTENDED NH FUNCTIONAL PREPOLYMER | AXALTA COATING SYSTEMS IP CO (US) | 2018-06-27 | — | — | EP | claimed |
| EP-0183552-B2 | A PHOTOPOLYMERIZABLE COMPOSITION | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1991-10-16 | — | — | EP | claimed |
| EP-0233299-B1 | OPTICAL RESIN AND PROCESS FOR PREPARING THE SAME | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1991-03-13 | — | — | EP | claimed |
| US-4855374-A | Optical resin from diallyl esters | NIPPON OIL AND FATS CO., LTD. (JP) | 1989-08-08 | — | — | US | claimed |
| EP-0266617-A2 | Modified polyphenylene ether resins having improved foamability and methods of making the same | GENERAL ELECTRIC COMPANY (US) | 1988-05-11 | — | — | EP | claimed |
| EP-0183552-B1 | A PHOTOPOLYMERIZABLE COMPOSITION | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1988-03-16 | — | — | EP | claimed |
| EP-0257486-A1 | Modified polyphenylene ether resins having improved processability and oxidative stability | GENERAL ELECTRIC COMPANY (US) | 1988-03-02 | — | — | EP | claimed |
| US-4728674-A | ALPHA, BETA-UNSATURATED CARBOXYLIC ACID DERIVATIVE | GENERAL ELECTRIC COMPANY (US) | 1988-03-01 | — | — | US | claimed |
| EP-0233299-A1 | Optical resin and process for preparing the same | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1987-08-26 | — | — | EP | claimed |
| US-4684669-A | LIGHTWEIGHT | GENERAL ELECTRIC COMPANY (US) | 1987-08-04 | — | — | US | claimed |
| EP-0183552-A2 | A photopolymerizable composition | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1986-06-04 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190111016-A1 | METHODS OF TREATING MUSCLE AND LIVER DISORDERS | CKMT1A; CKMT1B, CPT1B, GLS2 | HCAR2 2186/4885LMNA 511/4885AKR1B10 993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.